Remove Patient Care Remove Pharmaceutical Companies Remove Vaccines
article thumbnail

To help solve patient distrust in pharma, industry collaboration is key

pharmaphorum

The UK pharma sector should emerge from COVID-19 with a great deal of goodwill in the bank, especially after rapidly developing vaccines that are helping to steer the world out of the pandemic. There are plans by the UK health sector containing bold proposals to modernise patient information storage.

article thumbnail

Could virtual reality become an essential tool for healthcare education?

pharmaphorum

Practical examples of this include healthcare professionals using VR to learn various medical procedures or for the technology to be used to teach broader society about public health issues, such as the importance of vaccination. When both ‘treatments’ were combined, the vaccination intention increased even further. The more you know.

Vaccines 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Leveraging augmented analytics to drive better business decisions

pharmaphorum

In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). Yet a successful COVID-19 vaccine gained emergency approval in just 11 months, a blistering pace that likely saved millions of lives.

article thumbnail

AI’s infiltration of pharma: How COVID-19 accelerated change

pharmaphorum

The pharmaceutical industry has sometimes been a laggard in terms of digital maturity, but the COVID-19 crisis has provided companies the impetus to rapidly implement the most cutting-edge technologies. There are exciting developments happening for AI in healthcare – from drug discovery to diagnostics and care delivery.

Vaccines 132
article thumbnail

Steep drop for UK industry clinical trials between 2017 and 2021

European Pharmaceutical Review

The number of industry clinical trials initiated in the UK, per year, fell by 41 percent from 2017 to 2021, according to the latest annual report on clinical research from the Association of the British Pharmaceutical Industry ( ABPI ).

article thumbnail

Patient centricity and the changing pharmaceutical vista

pharmaphorum

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

article thumbnail

Five innovations shaping the future of pharmacy: 2024 highlights

Hospital Pharmacy Europe

Dr João Gonçalves PhD presents his pick for this year’s top five pharmacy innovations, illustrating how they set new standards for patient care and pharmaceutical development. Researchers have now adapted mRNA vaccines to target a range of other infectious diseases such as influenza, HIV and Zika.